دورية أكاديمية
أعرض في EDS

Successful Methotrexate Treatment of Chronic Chikungunya Arthritis.

التفاصيل البيبلوغرافية
العنوان: Successful Methotrexate Treatment of Chronic Chikungunya Arthritis.
المؤلفون: Amaral JK; From the Department of Infectious Diseases and Tropical Medicine, Federal University of Minas Gerais, Minas Gerais, Brazil., Bingham CO 3rd; Johns Hopkins Arthritis Center, Johns Hopkins University School of Medicine, Baltimore, MD., Schoen RT; Section of Rheumatology, Yale University School of Medicine, New Haven, CT.
المصدر: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2020 Apr; Vol. 26 (3), pp. 119-124.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9518034 Publication Model: Print Cited Medium: Internet ISSN: 1536-7355 (Electronic) Linking ISSN: 10761608 NLM ISO Abbreviation: J Clin Rheumatol Subsets: MEDLINE
أسماء مطبوعة: Publication: Philadelphia, PA : Lippincott Williams & Wilkins
Original Publication: Baltimore, MD : Williams & Wilkins, c1995-
مواضيع طبية MeSH: Antirheumatic Agents/*therapeutic use , Arthritis/*drug therapy , Chikungunya Fever/*drug therapy , Methotrexate/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Arthritis/diagnosis ; Arthritis/virology ; Brazil ; Chikungunya Fever/diagnosis ; Chikungunya virus ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
References: Yactayo S, Staples JE, Millot V, et al. Epidemiology of chikungunya in the Americas. J Infect Dis. 2016;214(Suppl 5):S441–S445.
Ganesan VK, Duan B, Reid SP. Chikungunya virus: pathophysiology, mechanism, and modeling. Viruses. 2017;9.
Pineda C, Munoz-Louis R, Caballero-Uribe CV, et al. Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems. Clin Rheumatol. 2016;35:2381–2385.
Petersen LR, Powers AM. Chikungunya: epidemiology. F1000Res. 2016;5.
Halstead SB. Reappearance of chikungunya, formerly called dengue, in the Americas. Emerg Infect Dis. 2015;21:557–561.
Nsoesie EO, Kraemer MU, Golding N, et al. Global distribution and environmental suitability for chikungunya virus, 1952 to 2015. Euro Surveill. 2016;21.
Borgherini G, Poubeau P, Jossaume A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis. 2008;47:469–475.
Wahid B, Ali A, Rafique S, et al. Global expansion of chikungunya virus: mapping the 64-year history. Int J Infect Dis. 2017;58:69–76.
Rodriguez-Morales AJ. Letter to the editor: chikungunya virus infection—an update on chronic rheumatism in Latin America. Rambam Maimonides Med J. 2017;8.
Ministry of Health of Brazil. Department of Health Surveillance. 2017 B. Monitoring of cases of dengue and chikungunya fever until epidemiological week, Brazil. Bol Epidemiol 2017;35. Available at: http://portalarquivos.saude.gov.br/images/pdf/2017/setembro/15/2017-028Monitoramento-dos-casos-de-dengue--febre-de-chikungunya-e-febre-pelo-virusZika-ate-a-Semana-Epidemiologica-35.pdf. Accessed October 17, 2017.
Galán-Huerta KJ, Rivas-Estilla A, Fernández-Salas I, et al. Chikungunya virus: a general overview. Med Univ. 2015;17:175–183.
Thiberville SD, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013;99:345–370.
Rodriguez-Morales AJ, Cardona-Ospina JA, Fernanda Urbano-Garzon S, et al. Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis. Arthritis Care Res. 2016;68:1849–1858.
Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009;76:654–657.
Marimoutou C, Ferraro J, Javelle E, et al. Chikungunya infection: self-reported rheumatic morbidity and impaired quality of life persist 6 years later. Clin Microbiol Infect. 2015;21:688–693.
Chaaithanya IK, Muruganandam N, Raghuraj U, et al. Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection. Indian J Med Res. 2014;140:142–145.
Tharmarajah K, Mahalingam S, Zaid A. Chikungunya: vaccines and therapeutics. F1000Res. 2017;6:2114.
Krutikov M, Manson J. Chikungunya virus infection: an update on joint manifestations and management. Rambam Maimonides Med J. 2016;7:1–7.
Marti-Carvajal A, Ramon-Pardo P, Javelle E, et al. Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: a systematic review. PloS one. 2017;12:e0179028.
Javelle E, Ribera A, Degasne I, et al. Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006–2012. PLoS Negl Trop Dis. 2015;9:e0003603.
Amaral JK, Schoen RT. Chikungunya in Brazil: rheumatologists on the frontline. J Rheumatol. 2018;45:726–728.
Schilte C, Staikowsky F, Couderc T, et al. Chikungunya virus–associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7:e2137.
Bouquillard E, Fianu A, Bangil M, et al. Rheumatic manifestations associated with chikungunya virus infection: a study of 307 patients with 32-month follow-up (RHUMATOCHIK study). Joint Bone Spine. 2018;85:207–210.
Mota MT, Terzian AC, Silva ML, et al. Mosquito-transmitted viruses—the great Brazilian challenge. Braz J Microbiol. 2016;47:38–50.
Brunier L, Polomat K, Deligny C, et al. Chikungunya virus infection in patients on biotherapies. Joint Bone Spine. 2016;83:245–246.
Malvy D, Ezzedine K, Mamani-Matsuda M, et al. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis. 2009;9:200.
Brighton SW, Simson IW. A destructive arthropathy following Chikungunya virus arthritis—a possible association. Clin Rheumatol. 1984;3:253–258.
Mathew AJ, Goyal V, George E, et al. Rheumatic-musculoskeletal pain and disorders in a naive group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract. 2011;65:1306–1312.
Moro ML, Grilli E, Corvetta A, et al. Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study. J Infect. 2012;65:165–172.
Chopra A, Anuradha V, Ghorpade R, et al. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect. 2012;140:842–850.
van Aalst M, Nelen CM, Goorhuis A, et al. Long-term sequelae of chikungunya virus disease: a systematic review. Travel Med Infect Dis. 2017;15:8–22.
Ramachandran V, Kaur P, Kanagasabai K, et al. Persistent arthralgia among Chikungunya patients and associated risk factors in Chennai South India. J Postgrad Med. 2014;60:3–6.
Murillo-Zamora E, Mendoza-Cano O, Trujillo-Hernandez B, et al. Persistent arthralgia and related risks factors in laboratory-confirmed cases of Chikungunya virus infection in Mexico. Rev Panam Salud Publica. 2017;41:e72.
Sissoko D, Malvy D, Ezzedine K, et al. Post-epidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3:e389.
Zeana C, Kelly P, Heredia W, et al. Post-chikungunya rheumatic disorders in travelers after return from the Caribbean. Travel Med Infect Dis. 2016;14:21–25.
Essackjee K, Goorah S, Ramchurn SK, et al. Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J. 2013;89:440–447.
Simon F, Javelle E, Cabie A, et al. French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Med Mal Infect. 2015;45:243–263.
Chang AY, Martins KAO, Encinales L, et al. Chikungunya arthritis mechanisms in the Americas: a cross-sectional analysis of chikungunya arthritis patients twenty-two months after infection demonstrating no detectable viral persistence in synovial Fluid. Arthritis Rheumatol. 2018;70:585–593.
Javelle E, Ribera A, Degasne I, et al. Clinical spectrum of post-chikungunya rheumatic musculoskeletal disorders and use of disease-modifying antirheumatic drugs to treat the chronic inflammatory entities: 6-year experience from Reunion Island. BMC Infect Dis. 2014;14:O20.
Amaral JK, Sutaria R, Schoen RT. Treatment of chronic chikungunya arthritis with methotrexate: a systematic review. Arthritis Care Res. 2018.
Ravindran V, Alias G. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol. 2017;36:1335–1340.
Pandya S. Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis: a 16 week study. Indian J Rheumatol. 2008;3:93–97.
Ahmed M, Shantharam N, Visweswara Reddy YJ. Randomized clinical trial in chikungunya arthritis cases. J Evol Med Dent Sci. 2012;1:841–847. DOI: 10.14260/jemds/135. (PMID: 10.14260/jemds/135)
Padmakumar B, Jayan JB, Menon RM, et al. Comparative evaluation of four therapeutic regimes in chikungunya arthritis: a prospective randomized parallel-group study. Indian J Rheumatol. 2009;4:94–101.
Chopra A, Saluja M, Venugopalan A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 2014;66:319–326.
Moore RA, Straube S, Aldington D. Pain measures and cut-offs—‘no worse than mild pain’ as a simple, universal outcome. Anaesthesia. 2013;68:400–412.
المشرفين على المادة: 0 (Antirheumatic Agents)
YL5FZ2Y5U1 (Methotrexate)
تواريخ الأحداث: Date Created: 20181207 Date Completed: 20210216 Latest Revision: 20210216
رمز التحديث: 20221213
DOI: 10.1097/RHU.0000000000000943
PMID: 30520824
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-7355
DOI:10.1097/RHU.0000000000000943